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• CAPCaT Fast-Track Program for SARS-CoV-2 Test Development 
• UMMS Update as of July 15, 2020 
• NIH Update as of July 15, 2020 
• COVID-19 Clinical Trials Database 
• The National COVID Cohort Collaborative (N3C) 
 
EVENTS 
• MALSI+ 2020 
 
FUNDING 
• CCTS SPARK Program (Small Pilot and Research Knowledge) 
• CTS Small Conference Grants 
• PRACCTIS program postdoctoral fellowship 
 
EDUCATION 
• Greater Worcester Covid-19 Survey 
• Patient-Facing Survey: What’s Your Take on New Medical Technology? 
  
DID YOU KNOW 
• HRPP QA/QI 
• National Center for Data to Health (CD2H)   
 
COVID-19 
UMASS CAPCaT TEAM LEADING EFFORT FOR COVID-19 TEST DEVELOPMENT AND 
DISTRIBUTION: The NIH is urgently soliciting proposals and can provide up to $500M across 
multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the 
public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx) is a fast-track 
technology development program that will support novel solutions that build the U.S. capacity 
for testing up to 100-fold above what is achievable with standard approaches. RADx is structured 
to deliver innovative testing strategies to the public as soon as late summer 2020 and is an 
accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily 
available to every American. 
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The application portal is now live www.poctrn.org/radx . 
For more information: https://www.youtube.com/watch?v=ofAldSGoZOg 
 
UMMS UPDATE regarding human subjects research during the COVID-19 pandemic can be 
found here: https://umassmed.edu/ccts/covid-19/. This website is updated frequently. 
 
NIH UPDATE: For up-to-date NIH COVID-19 information, including informational videos, 
proposal submission and award management resources, human subjects and clinical trials 
guidance, animal welfare, frequently asked questions regarding flexibilities for grantees, and 
funding opportunities, click here or copy and paste this url: https://www.nih.gov/health-
information/coronavirus  
 
CLINICAL TRIALS DATABASE: To search for active Covid-19 clinical trials, click here. 
 
THE NATIONAL COVID COHORT COLLABORATIVE (N3C): The National Center for Data to 
Health (CD2H) and NCATS are creating a centralized, secure portal for hosting row-level COVID-
19 clinical data – the National COVID Cohort Collaborative (N3C). This initiative is a partnership 
between the CTSA program, several HHS agencies, and the distributed clinical data networks 
PCORnet, OHDSI, ACT/i2b2, and TriNetX. We believe the N3C portal will enable the rapid 




MALSI+ 2020: August 20, 2020, 10AM-3PM 
A world-wide audience and the chance to win cash for your innovative idea-what could be 
better? Register now for the MALSI+ 2020 Technology Showcase and get ready to give 
your pitch to scientific innovators, entrepreneurs, business leaders, and investors from 
across the globe.  
  
Twenty presenters will be chosen to pitch, and we will award two cash prizes to the day's 
top presentations as determined by a panel of judges and an audience vote. Accepted 
pitches will receive coaching. All applications will receive feedback. 
  





CCTS SPARK PROGRAM: Rolling application deadline.  This program’s priorities are to support 
studies that impact clinical care and research methodologies, support students/trainees, and 
provide access to funds to generate pilot and preliminary data for external grant submissions.  
For more information, click on this link: https://www.umassmed.edu/ccts/funding/spark-
program/ 
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CCTS SMALL CONFERENCE GRANTS: Rolling application deadline.  This funding facilitates the 
development of faculty-to-faculty networks within the University system.  Click on this link for 
more information: https://umassmed.edu/ccts/funding/small-conference-grants/ 
FUNDING OPPORTUNITY: postdoctoral fellowships to prepare the next generation of scientists 
to conduct implementation research that addresses critical cancer prevention and control care 
delivery issues. 
 
PRACCTIS program postdoctoral fellowship: Funding opportunity!  Deadline extended for 
postdoctoral fellows. The National Cancer Institute-funded T32 PRACCTIS program (Prevention 
and Control of Cancer: Training for Change in Individuals and Systems) is now accepting 
applications for postdoctoral trainees to start August 2020 or later. PRACCTIS is an NCI-funded 
training program designed to prepare the next generation of scientists to conduct 
implementation research that addresses critical cancer prevention and control care delivery 
issues across the cancer continuum, including primary prevention, cancer screening, diagnosis, 
treatment and survivorship.  
• Trainees must be interested in pursuing a career focused on cancer prevention and 
control implementation research. All applicants must pursue independent research in this 
area.  
• Eligible trainees will have with doctoral degrees (MD, DO, Ph.D., Sc.D., etc.) and a primary 
mentor affiliated with one of the partnering institutions. External candidates will be 
matched with a mentor during the interview process. 
• Full applications are due by August 31, 2020. 




GREATER WORCESTER COVID-19 COMMUNITY HEALTH SURVEY: UMass Medical School, in 
collaboration with the City of Worcester and the Central Massachusetts Regional Public Health 
Alliance is conducting the Great Worcester COVID-19 Community Health Survey.  The online 
survey, which takes about 10 minutes to complete, asks respondents about changes in their 
lives due to COVID since March 10, including their health, finances, activities outside the home, 
access to medical care, employment, housing and food security. The names of the street a 
respondent lives on and the closest cross street will be vital for understanding circumstances in 
specific neighborhoods. Providing contact information is optional for respondents who want to 
receive survey results, and who are willing to be contacted about the survey. The survey also 
provides a list of local resources for households experiencing distress due to COVID-19. The 
survey is available in English, Spanish, Portuguese, Vietnamese, Albanian and Russian. To 
participate, please click here. 
UMASS PATIENT SURVEY: WHAT’S YOUR TAKE ON THE USE OF TECHNOLOGY IN HEALTH 
CARE? We want your advice on which new medical technologies should be developed to help 
you and your healthcare provider. We value your opinion about which medical tests you believe 
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would be most helpful. Your input is invaluable for guiding support toward products that will do 
the most good.  
 
Researchers at the University of Massachusetts focused on heart, lung, blood, and sleep disorders 
(CAPCaT) have created a brief survey that will help inform how we support promising new 
technologies. This survey has 21 questions and should take about 10 minutes to complete. 
Participation is entirely voluntary, and you can stop at any time. Your survey responses will be 
anonymous. Thank you in advance for providing critical feedback to CAPCaT. 
 
To participate click here: https://arcsapps.umassmed.edu/redcap/surveys/?s=AK3ET3RTLY 
 
If you have any questions, please contact Nate Hafer at nathaniel.hafer@umassmed.edu. 
 
 
DID YOU KNOW? 
 
HRPP QA/QI: The Human Research Protection Program (HRPP) Quality Assurance/Quality 
Improvement (QA/QI) Program is a component of the UMass Center for Clinical and 
Translational Science. The program is independent of the IRB and helps study teams and 
investigators by conducting routine post-approval monitoring of on-going research to evaluate 
adherence with institutional requirements and federal regulations. If there are review findings, 
the QA/QI manager shares those findings with investigators and study teams, and provides 
direct education on the findings, including how to avoid making similar errors in the future. In 
order to support improvement at an institutional level, the QA/QI manager shares aggregated 
data from reviews with the HRPP leadership and the Research Community to identify trends and 
target areas for education. The program also makes self-evaluation tools available to 
investigators and study teams seeking to perform their own assessments.  To learn more about 
HRPP QA/QI HRP-142, visit: https://www.umassmed.edu/globalassets/ccts/ccts-
media/irb/updated-sops-2015/hrp-142-hrpp-qa-qi-program-final.pdf. 
 
NATIONAL CENTER FOR DATA TO HEALTH (CD2H): The goal of CD2H is to make data more 
meaningful, open and accessible. The CD2H supports a vibrant and evolving collaborative 
informative ecosystem for the CTSA program and beyond. The CD2H harnesses and expands an 
ecosystem for translational scientists to discover and share their software, data and other 
research resources within the CTSA program network.  The CD2H also creates a social coding 
environment for translational science institutions, leveraging the community-driven DREAM 
challenges as a mechanism to stimulate innovation. To learn more, click here. 
 
SHARE YOUR SUCCESS STORY 
Have you had your research published that cites the UMass Center for Clinical and Translational 
Science?  Has your patent been filed on technology developed using Center funding or resources? 
Did your pilot project receive external grant funding? Share it with us at ccts@umassmed.edu. 
Sharing your success demonstrates the importance and effect of the Center for Clinical and 
Translational Science at UMass. 
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CITE & SUBMIT 
Please cite the NIH CTSA award any time you use The UMMS Center for Clinical and Translational 
Science resources, services and facilities or received funding through the Center. “The project 
described is supported by the National Center for Advancing Translational Sciences, 
National Institutes of Health, through Grant UL1 TR001453, (or TL1 TR001454, or KL2 
TR001455, as appropriate). The content is solely the responsibility of the authors and does 
not necessarily represent the official views of the NIH.”  
 
Newsletter Submissions: To be included in the CCTS Monthly Newsletter, please send 
announcements, including a link, to ccts@umassmed.edu. The newsletter is published the first week 
of each month. 
 
University of Massachusetts Center for Clinical and Translational Science, 55 Lake Avenue N, Worcester MA 01655 
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